Research Paper Volume 13, Issue 12 pp 16541—16566
Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment
Figure 6. Pan-cancer analysis of FGFR3 Copy Number Variant (CNV). (A) The CNV frequency of FGFR3 across various tumor types. (B) FGFR3 CNV distribution in pan-cancer and the top eight tumors for the cases with FGFR3 mutations simultaneously.